| Name | Title | Contact Details |
|---|
Wintersun Chemical LTD is a Ontario, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Southeastern Urological Center PA is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tallahassee, FL. To find more information about Southeastern Urological Center PA, please visit www.seuc.com
Comprehensive Clinical Development is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
People come to Murad when they`re ready to transform the life of their skin. Murad guarantees that transformation because only Murad combines advanced scientific research and practical clinical experience to create high performance skincare products, dietary supplements and lifestyle programs that help people look and feel their absolute best. As America`s first authentic doctor-developed brand, Murad remains true to the scientific principles of its founder, world-renowned dermatologist Howard Murad, M.D. Shaped by his Inclusive Health philosophy and inspired by the real problems of the more than 50,000 patients and clients who have visited his Los Angeles dermatology practice and Inclusive Health Spa®, his award-winning formulas have helped millions to resolve their skin issues. Through more than fifty years of research, Dr. Murad has established that beauty and health are vitally linked and best achieved through an Inclusive approach that improves every cell in the body. The result? The Murad Glow!
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.